Now that we've gotten our BIG announcement, where's the reward for those of us who have hung on until now? The preannouncement spike and encouraging opening where not followed by further increases, and EPIX has remained stagnant. I figure there could be a number of explanations, but I'd love some feedback from others with a vested interest in EPIX:
1) Few shareholders means few people who actively follow the stock, and people aren't clued in to the benefit of MS-325.
2) People expected the clinical trials to show MS-325 as 100% effective.
3) The market is waiting for news about the use of MS-325 in CAD, which appears to be the most significant application of the technology and probably its biggest money maker. (Does everyone agree with this?)
4) Most folks just don't understand the technology.
I am staying long on EPIX. Had the announcement been followed by a dive, I would be convinced there was something about this company I didn't understand. I've spoken with radiologists, IR at EPIX, and clinicians in other specialties, and have remained confident. Plus, the financial aspects of EPIX are enticing.
Earlier on this thread, someone said GE was committing to the development of MRI for use solely to diagnose CAD. Where can I find a reference to this? Has anyone spoken to Mallinckrodt to get their opinion of the results?
Funny how email on this thread dies when things are uncertain. I'd love to hear what others think, though.
You make some excellent points. I agree with all except (2). There may have been some confusion regarding the merits relative to X-ray, but the bottom line is that MS-325 is as effective. Maybe the company needs to make this clearer somehow.
We definitely suffered from the "buy on rumor, sell on fact" effect on Friday. Short term traders trying to make a few quick bucks drove the price down pretty sharply.
I will have to admit that I expected a little better bump up based on the announcement, and I still think it might happen. In my opinion, the only thing that will cause a significant near term rise is if management goes out on a road show to The Street. However, they really don't have a need to do that right now.
Long term, things look like they are progressing well. The company looks like they are going to really push to complete Phase 3 as soon as possible and get MS-325 on the market. That's when we will really be rewarded.